Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.

Junghoon Shin,Ji-Yeon Kim,Jung Min Oh,Jeong Eon Lee,Seok Won Kim,Seok Jin Nam,Won Park,Yeon Hee Park,Jin Seok Ahn,Young-Hyuck Im

Cancers（2023）

引用 1|浏览12

暂无评分

摘要

A small subset of patients with HER2+ MBC and metastatic TNBC may be curable with multimodality therapy. Prospective studies integrating clinical and genomic data may identify unique clinicogenomic features of MBC patients who can achieve durable disease control without prolonged chemotherapy.

查看译文

关键词

chemotherapy, endocrine therapy, HER2, hormone receptor, metastatic breast cancer, survival, triple-negative breast cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要